Explanations

Explaining High Drug Prices in the USA

Geoff Riley

4th February 2017

Share this content:

This short video from Bloomberg is ideal when teaching the economics of oligopoly, pricing power, the relative bargaining strength of drug sellers and buyers and the extent to which regulation is needed to avoid instances of price gouging in the pharmaceutical industry.

Explaining High Drug Prices in the USA

Share this content:

Geoff Riley

Geoff Riley FRSA has been teaching Economics for nearly forty years. He has over twenty years experience as Head of Economics at leading schools. He writes extensively and is a contributor and presenter on CPD and Revision conferences in the UK and overseas.

@tutor2uGeoff

Explore

More for students

Teaching Economics

Explaining High Drug Prices in the USA

Geoff Riley

You might also like

Micro Case Study: Tesco and Oligopoly

In the News Teaching Activity – What are the economic costs of insufficient vaccination uptake? (Jan 2026)

In the News Teaching Activity – How has Next benefited from the M&S cyber-attack? (Nov 2025)

Types of Collusion in Oligopoly Markets

Six Market Structures to Revise for Exams (2025 Focus)

The Baby Formula Price Trap: How Branding and Regulation Are Costing Parents

The Mobile Network Power Play: Vodafone and Three’s £16.5 billion Mega-Merger Explained

In the News Teaching Activity – why Gen Z is paying for ‘forever games’ (Dec 2024)

Explore

More for students

Subjects

Quick links

Student events & courses

Teaching Economics

Explaining High Drug Prices in the USA

Geoff Riley

You might also like